| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002626A2 Novel secreted proteins |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002621A2 Mammalian secreted proteins |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002604A2 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002602A2 Slgp protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002591A2 Peptides for use in culture media |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002213A1 Separation method |
| 01/10/2002 | WO2002002138A1 Treating endotoxemia and related disorders with probiotics |
| 01/10/2002 | WO2002002055A2 Antifungal compounds and methods of use |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2001075084A3 Coffee mannanase |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001055180A3 Gene cluster for everninomicin biosynthesis |
| 01/10/2002 | WO2001052668A3 Porphyrin containing lactic acid bacterial cells and use thereof |
| 01/10/2002 | WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001044480A3 Enzymes and genes used for producing vanillin |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001042422A3 Acyl glucosaminyl inositol amidase family and methods of use |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001037656A3 Preservation of sensitive biological material |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001011048B1 Therapeutic polypeptides and methods for using same |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004706 Apparatus and method for automated protein design |
| 01/10/2002 | US20020004590 Acid phosphatase |
| 01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004243 Method for introducing recessive properties into the genetic background of industrial baker's yeast |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004231 Microorganism for use in the generation of preferential amino acid |
| 01/10/2002 | US20020004229 Generating antibiotic; obtain vector, transform cell, express preferential enzyme in cells, recover antibiotic |
| 01/10/2002 | US20020004203 Reduced activity of polymerase chain reactions |
| 01/10/2002 | US20020004193 Novel MP-7 protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | DE10032174A1 Novel coryneform bacterium in which the gpsA gene encoding glycerol-3-phosphate dehydrogenase is enhanced, useful for fermentative production of L-amino acids such as L-lysine and L-glutamate |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415075A1 Novel secreted proteins |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414727A1 Elicitor from cladosporium |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414628A1 Method of improving biomass yield of lactic acid bacterial cultures |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412882A1 Peptide extended glycosylated polypeptides |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2408829A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | CA2406643A1 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/09/2002 | EP1170376A1 Method for producing substances utilizing microorganisms |
| 01/09/2002 | EP1170371A1 Phosphohexuloisomerase and gene therefor |
| 01/09/2002 | EP1170370A2 Method for producing nucleotide by fermentation |
| 01/09/2002 | EP1170369A1 Extracellular protease from acremonium chrysogenum with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin |
| 01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
| 01/09/2002 | EP1170362A2 Cloning and expressing restriction endonucleases and modification methylases from caryophanon |
| 01/09/2002 | EP1170361A2 New mutant N-Acetylglutamate synthase and method for L-Arginine production |
| 01/09/2002 | EP1170360A1 Yunnan sl-001 strain |
| 01/09/2002 | EP1170359A1 Biojelly-producing microorganism, coating containing said microorganism and anti-fouling method |
| 01/09/2002 | EP1170358A1 L-arginine producing Escherichia coli and method of producing L-arginine |
| 01/09/2002 | EP1169481A1 Method of identifying toxic agents using differential gene expression |
| 01/09/2002 | EP1169471A2 Method for screening compounds using nematode worms |